GSK Says Medicare Negotiations Are Complete and ‘In Line With Expectations’

And two companies push back on a 340B loophole that allows for-profit doctors access to 340B prices

Oct 30, 2025

Subscribe to Cost Curve Apex to read the rest.

Upgrade to Apex to get access to this post and other subscriber-only content.

No posts found